MA09.09 First-In-Human Phase 1 Study of ABBV-399, an Antibody-Drug Conjugate (ADC) Targeting C-Met, in Patients with Non-Small Cell Lung Cancer (NSCLC)

著录项

• 来源
  《Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer》 |2017年第1期|共2页
• 作者

  Eric Angevin; John Strickler; Colin Weekes; Rebecca Heist; Daniel Morgensztern; Xiaolin Fan; Ozzie Olyaie; Monica Motwani; Daniel Afar; Louie Naumovski; Karen Kelly;

  展开▼
• 作者单位

  Départment Innovations Thérapeutiques Et Essais Précoces (Ditep);

  Duke University Medical Center;

  University of Colorado;

  Massachusetts General Hospital for Children Cancer Center;

  Washington University School of Medicine;

  Abbvie Inc.;

  Abbvie Inc.;

  Abbvie Inc.;

  Abbvie Inc.;

  Abbvie Inc.;

  University of California Davis Comprehensive Cancer Center;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词